The Chemours Company (NYSE:CC - Get Free Report)'s share price fell 5.4% during trading on Friday . The company traded as low as $13.83 and last traded at $13.87. 646,632 shares changed hands during trading, a decline of 59% from the average session volume of 1,579,187 shares. The stock had previously closed at $14.67.
Analysts Set New Price Targets
A number of analysts have issued reports on CC shares. Truist Financial started coverage on Chemours in a research note on Tuesday, January 28th. They issued a "buy" rating and a $27.00 price objective on the stock. BMO Capital Markets decreased their price target on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 19th. Morgan Stanley lowered their price objective on shares of Chemours from $25.00 to $22.00 and set an "equal weight" rating for the company in a research report on Monday, January 13th. Royal Bank of Canada restated an "outperform" rating and issued a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Finally, The Goldman Sachs Group lowered their price target on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating for the company in a report on Tuesday, January 7th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $23.11.
Check Out Our Latest Analysis on Chemours
Chemours Trading Down 1.1 %
The stock has a fifty day moving average of $16.81 and a 200-day moving average of $18.30. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The company has a market cap of $2.14 billion, a PE ratio of 25.11 and a beta of 2.00.
Chemours (NYSE:CC - Get Free Report) last issued its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. Sell-side analysts anticipate that The Chemours Company will post 2.03 EPS for the current fiscal year.
Chemours Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 7.00%. The ex-dividend date was Friday, February 28th. Chemours's payout ratio is 175.44%.
Institutional Investors Weigh In On Chemours
Large investors have recently modified their holdings of the business. Polar Asset Management Partners Inc. purchased a new position in Chemours during the fourth quarter valued at approximately $2,392,000. iSAM Funds UK Ltd bought a new stake in Chemours during the fourth quarter valued at about $332,000. Vision One Management Partners LP grew its stake in Chemours by 12.1% in the fourth quarter. Vision One Management Partners LP now owns 1,558,498 shares of the specialty chemicals company's stock valued at $26,339,000 after purchasing an additional 168,148 shares during the last quarter. Two Sigma Advisers LP raised its holdings in Chemours by 31.5% in the fourth quarter. Two Sigma Advisers LP now owns 661,500 shares of the specialty chemicals company's stock worth $11,179,000 after purchasing an additional 158,400 shares in the last quarter. Finally, Two Sigma Investments LP lifted its position in shares of Chemours by 22.4% during the fourth quarter. Two Sigma Investments LP now owns 1,155,437 shares of the specialty chemicals company's stock valued at $19,527,000 after buying an additional 211,641 shares during the last quarter. Institutional investors own 76.26% of the company's stock.
About Chemours
(
Get Free Report)
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Read More
Before you consider Chemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemours wasn't on the list.
While Chemours currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
